Seeing Is Believing
Healthcare - Sector
MIRM is currently covered by 12 analysts with an average price target of $132.2. This is a potential upside of $32.56 (29.3%) from yesterday's end of day stock price of $102.24.
Mirum Pharmaceuticals's activity chart (see below) currently has 199 price targets and 173 ratings on display. The stock rating distribution of MIRM is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 79.7% with an average time for these price targets to be met of 417.45 days.
Highest price target for MIRM is $175, Lowest price target is $77, average price target is $132.2.
Most recent stock forecast was given by JOSEPH THOME from TD COWEN on 06-Aug-2026. First documented stock forecast 12-Aug-2019.
Currently out of the existing stock ratings of MIRM, 38 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 26-Feb-2026
$140
$39.36 (39.11%)
$145
Buy Since 19-May-2025
$140
$39.36 (39.11%)
$175
Buy Since 20-Sep-2023
$137
$36.36 (36.13%)
$146
Buy Since 21-Sep-2021
$125
$24.36 (24.21%)
$77
Buy Since 13-Nov-2023
$150
$26.23 (21.19%)
$140
What is MIRM (Mirum Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on MIRM (Mirum Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on MIRM (Mirum Pharmaceuticals)?
Which analyst is the currently most bullish on MIRM (Mirum Pharmaceuticals)?
Which analyst is the currently most reserved on MIRM (Mirum Pharmaceuticals)?